サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1063053

癌治療薬の世界市場：2022年

Oncology Drugs Global Market Report 2022
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 300 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
癌治療薬の世界市場：2022年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 300 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界の癌治療薬市場について調査し、市場の特性、規模と成長、地域・国別動向、競合情勢、市場シェア、市場動向と戦略を網羅しています。また、セグメント別の市場の実績と予測、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの構造

第3章 癌治療薬市場の特徴

  • 市場の定義
  • 主要なセグメンテーション

第4章 癌治療薬市場の製品分析

  • 主要な製品/サービス
  • 主な機能と差別化要因
  • 開発製品

第5章 癌治療薬市場のサプライチェーン

  • サプライチェーン
  • 流通
  • 最終顧客

第6章 癌治療薬市場の顧客情報

  • 顧客の好み
  • 最終用途の市場規模と成長

第7章 癌治療薬市場の動向と戦略

第8章 癌治療薬に対するCOVID-19の影響

第9章 癌治療薬の市場規模と成長

  • 市場規模
  • 市場成長実績、金額（10億米ドル）
    • 市場の促進要因
    • 市場の抑制要因
  • 市場成長予測、金額（10億米ドル）
    • 市場の促進要因
    • 市場の抑制要因

第10章 癌治療薬市場の地域別分析

  • 世界の癌治療薬市場、2021年、地域別、金額（10億米ドル）
  • 世界の癌治療薬市場、2016年～2021年、2021年～2026年、2031年、実績および予測、地域別
  • 世界の癌治療薬市場、成長および市場シェアの比較、地域別

第11章 癌治療薬市場のセグメンテーション

  • 世界の癌治療薬市場、タイプ別セグメンテーション、実績および予測、2016年～2021年、2021年～2026年、2031年、10億米ドル
  • 医薬品
  • 生物製剤
  • 世界の癌治療薬市場、薬剤タイプ別セグメンテーション、実績および予測、2016年～2021年、2021年～2026年、2031年、10億米ドル
  • 化学療法
  • ホルモン療法
  • 標的療法
  • 肺癌
  • 膵臓癌
  • 乳癌
  • 前立腺癌
  • 卵巣癌
  • 結腸直腸癌
  • 胃癌
  • 腎臓癌
  • 脳腫瘍
  • 甲状腺癌
  • 皮膚癌
  • 膀胱癌
  • 子宮頸癌
  • 血液癌
  • その他
  • 世界の癌治療薬市場、流通チャネル別セグメンテーション、実績および予測、2016年～2021年、2021年～2026年、2031年、10億米ドル
  • 院内薬局
  • 小売薬局/ドラッグストア
  • その他
  • 世界の癌治療薬市場、投与経路別セグメンテーション、実績および予測、2016年～2021年、2021年～2026年、2031年、10億米ドル
  • 経口
  • 非経口
  • その他
  • 世界の癌治療薬市場、薬剤分類別セグメンテーション、実績および予測、2016年～2021年、2021年～2026年、2031年、10億米ドル
  • ブランド薬
  • ジェネリック薬

第12章 癌治療薬市場の指標

  • 世界の癌治療薬の市場規模、GDPに占める割合、2016年～2026年
  • 世界の一人当たりの癌治療薬市場平均支出、2016年～2026年

第13章 アジア太平洋の癌治療薬市場

第14章 西欧の癌治療薬市場

第15章 東欧の癌治療薬市場

第16章 北米の癌治療薬市場

第17章 南米の癌治療薬市場

第18章 中東の癌治療薬市場

第19章 アフリカの癌治療薬市場

第20章 癌治療薬市場の競合情勢

  • 競争市場概要
  • 市場シェア
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Novartis AG
    • Gilead Sciences Inc
    • Bayer AG
    • Takeda Pharmaceticals

第21章 癌治療薬市場における主要な合併と買収

第22章 市場の背景：医薬品市場

第23章 推奨事項

第24章 付録

第25章 著作権と免責事項

目次
Product Code: r681

“Oncology Drugs Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oncology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Oncology Drugs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oncology drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oncology drugs market section of the report gives context. It compares the oncology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology drugs indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Pharmaceutical Drugs; Biologics
  • 2) By DrugType: Chemotherapy; Harmone Therapy; Targeted Therapy; Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Tumor; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  • 3) By Distribution Channel: Hospital Pharmacies; Online Stores; Others
  • 4) By Route Of Administration: Oral; Parenteral; Others
  • 5) By Drug Classification: Branded Drugs; Generic Drugs
  • Companies Mentioned: F.Hoffmann-La Roche Ltd.; Novartis AG; Gilead Sciences Inc.; Bayer AG; Takeda Pharmaceticals
  • Metrics Covered: Number of Enterprises; Number of Employees
  • Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, oncology drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Oncology Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Oncology Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Oncology Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Oncology Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Oncology Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Oncology Drugs

9. Oncology Drugs Market Size And Growth

  • 9.1. Market Size
  • 9.2. Historic Market Growth, Value ($ Billion)
    • 9.2.1. Drivers Of The Market
    • 9.2.2. Restraints On The Market
  • 9.3. Forecast Market Growth, Value ($ Billion)
    • 9.3.1. Drivers Of The Market
    • 9.3.2. Restraints On The Market

10. Oncology Drugs Market Regional Analysis

  • 10.1. Global Oncology Drugs Market, 2021, By Region, Value ($ Billion)
  • 10.2. Global Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 10.3. Global Oncology Drugs Market, Growth And Market Share Comparison, By Region

11. Oncology Drugs Market Segmentation

  • 11.1. Global Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Pharmaceutical Drugs
  • Biologics
  • 11.2. Global Oncology Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Chemotherapy
  • Harmone Therapy
  • Targeted Therapy
  • Lung Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Prostate Cancer;
  • Ovarian Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Kidney Cancer
  • Brain Tumor
  • Thyroid Cancer
  • Skin Cancer
  • Bladder Cancer
  • Cervical Cancer
  • Blood Cancer
  • Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
  • 11.3. Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
  • 11.4. Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oral
  • Parenteral
  • Others
  • 11.5. Global Oncology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Branded Drugs
  • Generic Drugs

12. Oncology Drugs Market Metrics

  • 12.1. Oncology Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • 12.2. Per Capita Average Oncology Drugs Market Expenditure, 2016-2026, Global

13. Asia-Pacific Oncology Drugs Market

  • 13.1. Asia-Pacific Oncology Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. Asia-Pacific, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • 13.3. Asia-Pacific, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 13.4. Asia-Pacific, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 13.5. Asia-Pacific, Oncology Drugs Market Metrics
    • 13.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, Asia-Pacific Countries
    • 13.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Asia-Pacific Countries
  • 13.6. Asia-Pacific Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 13.7. Asia-Pacific Oncology Drugs Market: Country Analysis
    • 13.7.1. China Oncology Drugs Market
      • 13.7.1.1. China Oncology Drugs Market Overview
      • 13.7.1.2. China Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.1.3. China Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.2. Australia Oncology Drugs Market
      • 13.7.2.1. Australia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.2.2. Australia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.3. Hong Kong Oncology Drugs Market
      • 13.7.3.1. Hong Kong Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.4. India Oncology Drugs Market
      • 13.7.4.1. India Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.4.2. India Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.5. Indonesia Oncology Drugs Market
      • 13.7.5.1. Indonesia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.5.2. Indonesia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.6. Japan Oncology Drugs Market
      • 13.7.6.1. Japan Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.6.2. Japan Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.7. Malaysia Oncology Drugs Market
      • 13.7.7.1. Malaysia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.8. New Zealand Oncology Drugs Market
      • 13.7.8.1. New Zealand Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.9. Philippines Oncology Drugs Market
      • 13.7.9.1. Philippines Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.10. Singapore Oncology Drugs Market
      • 13.7.10.1. Singapore Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.11. South Korea Oncology Drugs Market
      • 13.7.11.1. South Korea Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.11.2. South Korea Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.12. Thailand Oncology Drugs Market
      • 13.7.12.1. Thailand Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.13. Vietnam Oncology Drugs Market
      • 13.7.13.1. Vietnam Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14. Western Europe Oncology Drugs Market

  • 14.1. Western Europe Oncology Drugs Market Overview
  • 14.2. Western Europe, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • 14.3. Western Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 14.4. Western Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 14.5. Western Europe, Oncology Drugs Market Metrics
    • 14.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, Western Europe Countries
    • 14.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Western Europe Countries
  • 14.6. Western Europe Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 14.7. Western Europe Oncology Drugs Market: Country Analysis
    • 14.7.1. Austria Oncology Drugs Market
      • 14.7.1.1. Austria Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.2. Belgium Oncology Drugs Market
      • 14.7.2.1. Belgium Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.3. Denmark Oncology Drugs Market
      • 14.7.3.1. Denmark Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.4. Finland Oncology Drugs Market
      • 14.7.4.1. Finland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.5. France Oncology Drugs Market
      • 14.7.5.1. France Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.5.2. France Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.6. Germany Oncology Drugs Market
      • 14.7.6.1. Germany Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.6.2. Germany Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.7. Ireland Oncology Drugs Market
      • 14.7.7.1. Ireland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.8. Italy Oncology Drugs Market
      • 14.7.8.1. Italy Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.9. Netherlands Oncology Drugs Market
      • 14.7.9.1. Netherlands Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.10. Norway Oncology Drugs Market
      • 14.7.10.1. Norway Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.11. Portugal Oncology Drugs Market
      • 14.7.11.1. Portugal Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.12. Spain Oncology Drugs Market
      • 14.7.12.1. Spain Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.13. Sweden Oncology Drugs Market
      • 14.7.13.1. Sweden Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.14. Switzerland Oncology Drugs Market
      • 14.7.14.1. Switzerland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.15. UK Oncology Drugs Market
      • 14.7.15.1. UK Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.15.2. UK Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15. Eastern Europe Oncology Drugs Market

  • 15.1. Eastern Europe Oncology Drugs Market Overview
  • 15.2. Eastern Europe, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • 15.3. Eastern Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 15.4. Eastern Europe, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 15.5. Eastern Europe, Oncology Drugs Market Metrics
    • 15.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, Eastern Europe Countries
    • 15.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Eastern Europe Countries
  • 15.6. Eastern Europe Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 15.7. Eastern Europe Oncology Drugs Market: Country Analysis
    • 15.7.1. Czech Republic Oncology Drugs Market,
      • 15.7.1.1. Czech Republic Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.2. Poland Oncology Drugs Market
      • 15.7.2.1. Poland Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.3. Romania Oncology Drugs Market
      • 15.7.3.1. Romania Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.4. Russia Oncology Drugs Market
      • 15.7.4.1. Russia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 15.7.4.2. Russia Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16. North America Oncology Drugs Market

  • 16.1. North America Oncology Drugs Market Overview
  • 16.2. North America, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • 16.3. North America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 16.4. North America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 16.5. North America, Oncology Drugs Market Metrics
    • 16.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, North America Countries
    • 16.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, North America Countries
  • 16.6. North America Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 16.7. North America Oncology Drugs Market: Country Analysis
    • 16.7.1. Canada Oncology Drugs Market
      • 16.7.1.1. Canada Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.2. Mexico Oncology Drugs Market
      • 16.7.2.1. Mexico Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.3. USA Oncology Drugs Market
      • 16.7.3.1. USA Oncology Drugs Market Overview
      • 16.7.3.2. USA Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 16.7.3.3. USA Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17. South America Oncology Drugs Market

  • 17.1. South America Oncology Drugs Market Overview
  • 17.2. South America, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • 17.3. South America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 17.4. South America, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 17.5. South America, Oncology Drugs Market Metrics
    • 17.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, South America Countries
    • 17.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, South America Countries
  • 17.6. South America Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 17.7. South America Oncology Drugs Market: Country Analysis
    • 17.7.1. Argentina Oncology Drugs Market
      • 17.7.1.1. Argentina Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.2. Brazil Oncology Drugs Market
      • 17.7.1.1. Brazil Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 17.7.2.2. Brazil Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.3. Chile Oncology Drugs Market
      • 17.7.3.1. Chile Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.4. Colombia Oncology Drugs Market
      • 17.7.4.1. Colombia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.5. Peru Oncology Drugs Market
      • 17.7.5.1. Peru Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.6. Venezuela Oncology Drugs Market
      • 17.7.6.1. Venezuela Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18. Middle East Oncology Drugs Market

  • 18.1. Middle East Oncology Drugs Market Overview
  • 18.2. Middle East, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • 18.3. Middle East, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 18.4. Middle East, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 18.5. Middle East, Oncology Drugs Market Metrics
    • 18.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, Middle East Countries
    • 18.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Middle East Countries
  • 18.6. Middle East Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 18.7. Middle East Oncology Drugs Market: Country Analysis
    • 18.7.1. Saudi Arabia Oncology Drugs Market
      • 18.7.1.1. Saudi Arabia Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.2. Israel Oncology Drugs Market
      • 18.7.2.1. Israel Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.3. Turkey Oncology Drugs Market
      • 18.7.3.1. Turkey Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.4. UAE Oncology Drugs Market
      • 18.7.4.1. UAE Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19. Africa Oncology Drugs Market

  • 19.1. Africa Oncology Drugs Market Overview
  • 19.2. Africa, Oncology Drugs Market, 2021, By Country, Value ($ Billion)
  • 19.3. Africa, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 19.4. Africa, Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 19.5. Africa, Oncology Drugs Market Metrics
    • 19.5.1. Per Capita Average Oncology Drugs Expenditure, 2016-2026, Africa Countries
    • 19.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2021, Africa Countries
  • 19.6. Africa Oncology Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 19.7. Africa Oncology Drugs Market: Country Analysis
    • 19.7.1. Egypt Oncology Drugs Market
      • 19.7.1.1. Egypt Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.2. Nigeria Oncology Drugs Market
      • 19.7.2.1. Nigeria Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.3. South Africa Oncology Drugs Market
      • 19.7.3.1. South Africa Oncology Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

20. Oncology Drugs Market Competitive Landscape

  • 20.1. Competitive Market Overview
  • 20.2. Market Shares
  • 20.3. Company Profiles
    • 20.3.1. F. Hoffmann-La Roche Ltd
      • 20.3.1.1. Company Overview
      • 20.3.1.2. Products And Services
      • 20.3.1.3. Strategy
      • 20.3.1.4. Financial Performance
    • 20.3.2. Novartis AG
      • 20.3.2.1. Company Overview
      • 20.3.2.2. Products And Services
      • 20.3.2.3. Strategy
      • 20.3.2.4. Financial Performance
    • 20.3.3. Gilead Sciences Inc
      • 20.3.3.1. Company Overview
      • 20.3.3.2. Products And Services
      • 20.3.3.3. Strategy
      • 20.3.3.4. Financial Performance
    • 20.3.4. Bayer AG
      • 20.3.4.1. Company Overview
      • 20.3.4.2. Products And Services
      • 20.3.4.3. Strategy
      • 20.3.4.4. Financial Performance
    • 20.3.5. Takeda Pharmaceticals
      • 20.3.5.1. Company Overview
      • 20.3.5.2. Products And Services
      • 20.3.5.3. Strategy
      • 20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Oncology Drugs Market

22. Market Background: Pharmaceutical Drugs Market

  • 22.1. Pharmaceutical Drugs Market Characteristics
  • 22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global
  • 22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • 22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

23. Recommendations

  • 23.1. Global Oncology Drugs Market In 2026- Growth Countries
  • 23.2. Global Oncology Drugs Market In 2026- Growth Segments
  • 23.3. Global Oncology Drugs Market In 2026- Growth Strategies

24. Appendix

  • 24.1. NAICS Definitions Of Industry Covered In This Report
  • 24.2. Abbreviations
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company

25. Copyright And Disclaimer